Purpose:
The objective of the study is to compare the safety and gastrointestinal tolerability of ferric maltol oral suspension and ferrous sulfate oral liquid in children and adolescents aged 2 years to 17 years, and assess the safety and tolerability of ferric maltol oral suspension in children 1 month to less than 2 years, in the treatment of iron deficiency anemia during the 12 weeks treatment period.
What to Expect:
Participation in the anemia / iron deficiency study lasts approximately 12 weeks and includes visits to the study site. Qualifying participants may be compensated for their time and travel.
Eligibility Criteria:
Participant must:
Length / Duration:
Participation in this comparative study lasts approximately 12 weeks and includes follow up visits to the study site and supervised dosing by parent/legal guardian for children/adolescents throughout the treatment period and recorded on a dosing diary.
Location:
3229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Who should you contact:
Recruitment Department: (407) 350-3979
Tell us a little bit about yourself. We will contact you for additional information to determine your eligibility for current and future studies.
3229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2023 Kissimmee Clinical Research- All rights reserved
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.